- Ultra-low doses could bring costly cancer treatments to more patients in poorer countriesLow-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.STAT · 1mo ago↗ source
- STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drugMuch-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in pancreatic cancer.STAT · 1mo ago↗ source
- STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancerA lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.STAT